Intercept Pharma's new liver disease drug comes with hefty price tag: $70000 a year - MarketWatch

MarketWatch

Intercept Pharma's new liver disease drug comes with hefty price tag: $70000 a year MarketWatch For the last two decades, there's been little recourse for patients with the rare, chronic disease primary biliary cholangitis — which causes the liver to deteriorate — who didn't respond well to the only treatment option. Those patients, up to 40 ... and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHL-tVmk9t7Q7fKfN3mNd1Pf-KXyQ&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779123871458&ei=R9VNV7CoF5LK3QH_24yABw&url=http://www.marketwatch.com/story/intercept-pharmas-new-liver-disease-drug-comes-with-hefty-price-tag-70000-a-year-2016-05-31
via IFTTT